Melexis Nv Stock Performance
| MLXSF Stock | USD 74.25 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.79, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Melexis NV's returns are expected to increase less than the market. However, during the bear market, the loss of holding Melexis NV is expected to be smaller as well. At this point, Melexis NV has a negative expected return of -0.47%. Please make sure to verify Melexis NV's variance and kurtosis , to decide if Melexis NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Melexis NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 35 M | |
| Free Cash Flow | 148 M |
Melexis |
Melexis NV Relative Risk vs. Return Landscape
If you would invest 10,727 in Melexis NV on September 1, 2024 and sell it today you would lose (3,302) from holding Melexis NV or give up 30.78% of portfolio value over 90 days. Melexis NV is currently producing negative expected returns and takes up 4.0232% volatility of returns over 90 trading days. Put another way, 35% of traded pink sheets are less volatile than Melexis, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Melexis NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Melexis NV's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Melexis NV, and traders can use it to determine the average amount a Melexis NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1171
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MLXSF |
Estimated Market Risk
| 4.02 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Melexis NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Melexis NV by adding Melexis NV to a well-diversified portfolio.
Melexis NV Fundamentals Growth
Melexis Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Melexis NV, and Melexis NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Melexis Pink Sheet performance.
| Return On Equity | 0.45 | |||
| Return On Asset | 0.27 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 3.55 B | |||
| Shares Outstanding | 40.4 M | |||
| Price To Earning | 21.34 X | |||
| Price To Book | 5.79 X | |||
| Price To Sales | 4.74 X | |||
| Revenue | 836.16 M | |||
| EBITDA | 271.7 M | |||
| Cash And Equivalents | 116.56 M | |||
| Cash Per Share | 2.89 X | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 11.92 X | |||
| Cash Flow From Operations | 187.84 M | |||
| Earnings Per Share | 4.72 X | |||
| Total Asset | 580.23 M | |||
About Melexis NV Performance
By analyzing Melexis NV's fundamental ratios, stakeholders can gain valuable insights into Melexis NV's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Melexis NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Melexis NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is traded on OTC Exchange in the United States.Things to note about Melexis NV performance evaluation
Checking the ongoing alerts about Melexis NV for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Melexis NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Melexis NV generated a negative expected return over the last 90 days | |
| Melexis NV has high historical volatility and very poor performance |
- Analyzing Melexis NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Melexis NV's stock is overvalued or undervalued compared to its peers.
- Examining Melexis NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Melexis NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Melexis NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Melexis NV's pink sheet. These opinions can provide insight into Melexis NV's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Melexis Pink Sheet analysis
When running Melexis NV's price analysis, check to measure Melexis NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Melexis NV is operating at the current time. Most of Melexis NV's value examination focuses on studying past and present price action to predict the probability of Melexis NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Melexis NV's price. Additionally, you may evaluate how the addition of Melexis NV to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |